Switchbacksys
San Francisco Bay Area, US · Founded 2019 · 4 known investors
Find your way into Switchbacksys
Switchback Systems develops a benchtop DNA synthesis platform that combines onboard oligonucleotide synthesis and gene assembly, aimed at putting synthetic biology tools directly in scientists' hands. It targets researchers across industries such as pharmaceuticals, agriculture, and plastics, positioning itself in the synthetic biology and DNA synthesis market.
Founders & leadership
MN
Mary NoeinExecutive
Board
TR
Timothy RichardsonBoard director
PC
AC
A Craig AsherBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$18.1M disclosed across 2 rounds · 2020–2024
▶$11.3MraisedAug 2024 · 8 investors · BiotechnologyRule 506(b)
▶$11.3MraisedAug 2024 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mary NoeExecutive Officer, Director
- Craig AsherDirector
- Jason MyersExecutive Officer
- Brian ConnExecutive Officer
- Offering amount
- $15M
- Amount sold
- $11.3M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedOct 2023 · 7 investors · BiotechnologyRule 506(b)
▶$6.7MraisedOct 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mary NoeExecutive Officer, Director
- Timothy RichardsonDirector
- Paul ConleyDirector
- A Craig AsherDirector
- Offering amount
- $12.8M
- Amount sold
- $6.7M
- Proceeds to insiders
- $120K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Switchbacksys do?
- Switchback Systems develops a benchtop DNA synthesis platform that combines onboard oligonucleotide synthesis and gene assembly, aimed at putting synthetic biology tools directly in scientists' hands. It targets researchers across industries such as pharmaceuticals, agriculture, and plastics, positioning itself in the synthetic biology and DNA synthesis market.
- Who are Switchbacksys's investors?
- Switchbacksys's investors include Ahren Innovation Capital, GENERAL INCEPTION, Vertical Venture Partners, OMX Ventures.
- How much funding has Switchbacksys raised?
- Switchbacksys has disclosed $18.1M raised across 2 rounds.
- Where is Switchbacksys headquartered?
- Switchbacksys is headquartered in San Francisco Bay Area, US.